Want to join the conversation?
Construction company $JEC said that it was awarded a contract to expand the Novartis Pharma SAS Biotechnology Center in France. As per the agreement, $JEC is providing engineering, procurement & construction management (EPCM) services to increase the site's production capacity by 70% & create a second line of purification for making multiple drugs.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.